Validation of the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) chronic kidney disease risk score in HIV-infected patients in the USA.
A M MillsK L SchulmanJennifer S FuscoLaurence BrunetR HsuA BeyerG PrajapatiK MounzerG P FuscoPublished in: HIV medicine (2020)
The findings support the validity of the D:A:D risk scoring method for assessing CKD (stages 3-5) probability in an exclusively USA-based sample regardless of eGFR method.
Keyphrases
- hiv infected patients
- antiretroviral therapy
- chronic kidney disease
- hiv infected
- end stage renal disease
- hiv positive
- human immunodeficiency virus
- hiv aids
- small cell lung cancer
- hepatitis c virus
- epidermal growth factor receptor
- tyrosine kinase
- electronic health record
- hiv testing
- big data
- data analysis
- peritoneal dialysis
- clinical evaluation